Surgical Site Infection after Orthopedic Surgery Performed in Dong Guan Hospital of Traditional Chinese Medicine: A Descriptive Study of the Burden of Surgical Site Infection and its Risk factors with A Focus on Antimicrobial Prophylaxis and Traditional Chinese Medicine in Spinal Surgery by Wang, Jiancong
  
 
Surgical Site Infection after Orthopedic Surgery Performed in Dong 
Guan Hospital of Traditional Chinese Medicine: A Descriptive Study 
of the Burden of Surgical Site Infection and its Risk factors with A 
Focus on Antimicrobial Prophylaxis and Traditional Chinese Medicine 
in Spinal Surgery 
 
Jiancong Wang 
 
 
 
Supervisor: Dr. Hanne Merete Eriksen 
Co-supervisor: Prof. Gunnar Aksel Bjune 
 
University of Oslo, Faculty of Medicine 
Institute of Health and Society, Department of Community Medicine 
Section for International Community Health 
Thesis submitted as a part of the Master of Philosophy Degree  
in International Community Health 
11 May 2015 
I 
 
Contents 
Acknowledgements ............................................................................................................................ IV 
Abstract ............................................................................................................................................... V 
Acronyms and abbreviations .............................................................................................................. VI 
1 Introduction ....................................................................................................................................... 1 
1.1 Burden of endemic healthcare-associated infections ................................................................. 1 
1.2 Burden and consequences of surgical site infection ................................................................... 2 
1.3 Surgical site infection detected in post-hospital discharge surveillance .................................... 4 
1.4 Risk factors of surgical site infection after spinal surgery ......................................................... 5 
1.5 Prophylactic antimicrobial of administration ............................................................................. 5 
1.6 Microorganism of orthopedic surgeries ...................................................................................... 6 
2 Rationale of the study ....................................................................................................................... 6 
3 Objectives and research questions .................................................................................................... 7 
Overall objective .............................................................................................................................. 7 
Specific aims .................................................................................................................................... 8 
4 Materials and methods ...................................................................................................................... 8 
4.1 Brief description of the study site ............................................................................................... 8 
4.2 Dong Guan Hospital of Traditional Chinese Medicine and its surveillance and infectious 
control program ................................................................................................................................ 9 
4.3 Traditional Chinese Medicine used in Dong Guan Hospital of Traditional Chinese Medicine10 
4.4 Rationale for the choice of research method ............................................................................ 10 
4.5 Research design ........................................................................................................................ 11 
4.6 Study population ....................................................................................................................... 11 
4.7 Sample size calculation ............................................................................................................ 11 
II 
 
4.8 Definition of surgical site infection .......................................................................................... 11 
4.9 The preparation of the study ..................................................................................................... 11 
4.10 Sources of information ........................................................................................................... 12 
4.11 Surgical site infection registration .......................................................................................... 12 
4.12 Data collection and case finding ............................................................................................. 13 
4.13 Post-discharge surveillance and case finding ......................................................................... 13 
4.14 Microorganism........................................................................................................................ 14 
4.15 Included variables and data handling ..................................................................................... 14 
4.16 Data validation ........................................................................................................................ 15 
4.17 Training ................................................................................................................................... 15 
5 Statistical analysis ........................................................................................................................... 15 
6 Ethical considerations ..................................................................................................................... 16 
7 Results ............................................................................................................................................. 16 
7.1 General description and demographical data ........................................................................... 16 
7.2 Surgical site infection detected during in-hospital and post-discharge .................................... 17 
7.3 Risk factors for spinal surgery .................................................................................................. 18 
7.4 Routines of antimicrobial prophylaxis and traditional Chinese medicine ................................ 18 
7.5 Microorganism.......................................................................................................................... 19 
8 Discussions...................................................................................................................................... 23 
8.1 Incidence proportion of surgical site infection ......................................................................... 23 
8.2 Risk factors for spinal surgery .................................................................................................. 24 
8.3 Antimicrobials prophylaxis ...................................................................................................... 25 
8.4 Traditional Chinese Medicine ................................................................................................... 25 
8.5 Microorganism.......................................................................................................................... 26 
III 
 
9 Limitations ...................................................................................................................................... 26 
10 Strengths........................................................................................................................................ 27 
11 Recommendations ......................................................................................................................... 27 
12 Conclusions ................................................................................................................................... 28 
13 Appendices .................................................................................................................................... 29 
Annex 1 Criteria for Defining a Surgical Site Infection developed by CDC ................................. 29 
Annex 2 Wound contamination class ............................................................................................. 31 
Annex 3 The American Society of Anesthesiology physical status classifications ........................ 32 
Annex 4 Wound bacterial cultures .................................................................................................. 32 
Annex 5 Antimicrobial prophylaxes ............................................................................................... 33 
Annex 6 Definition of the variables included for surveillance of surgical site infection ............... 35 
Annex 7 Definition of incidence rate of orthopaedic spinal SSI and its possible risk factors ....... 38 
Annex 8 Specific functions of common traditional Chinese medicine constituents ...................... 38 
Annex 9 The questionnaire for patients with orthopedic surgery................................................... 39 
Annex 10 The questionnaires for the patients discharge after 30 days of surgery ......................... 40 
Annex 11 Ethical Clearances in Norway ........................................................................................ 41 
Annex 12 Ethical Clearances in China ........................................................................................... 43 
Annex 13 Ethical Clearances in China (Translation version) ........................................................ 45 
Annex 14 Supporting letter from the University of Oslo ............................................................... 47 
14 References ..................................................................................................................................... 48 
15 Manuscript for submission to the Journal of Hospital Infection ................................................... 54 
 
 
 
 
IV 
 
Acknowledgements  
At first I would like to express my sincere appreciation to my supervisors, Dr. Hanne Merete 
Eriksen and Prof. Gunnar Aksel Bjune for their constructive guidance, supports and 
encouragements throughout my study and research process. They made me have such a great career 
in the two-year M.Phil research program in University of Oslo. Without them, this project would 
never have been possible. 
 
I should thank to Prof. Magne Thoresen and Dr. Ibrahimu Mdala from University of Oslo to support 
on quantitative and statistical analysis on this project. Exclusive thanks should go to Prof. Akhtar 
Hussain and Prof. Johanne Sundby, and all the other professors who contributed to this master 
program. Thanks to all administrative staff at the department, especially Terese Eriksen who gave 
me a lot support and encouragement to overcome the challenges and difficulties during in my 
fieldwork and my study period. And a lot of thanks shall go to my classmate Dr. Socheat Cheng and 
my best friend Dr. Yuchuan Li in Norway for their genuine friendship. 
 
I also wish to express my thanks to Dr. Xiaoyan Lu, the Dean of the Department of HAI-control; 
and Dr. Zhiwen Zheng, the President of the Dong Guan Hospital of Traditional Chinese Medicine 
for the greatest support of my study in Oslo and permit for this research. I sincerely express thanks 
to my colleagues Xinlei Ma, Kexin Qi, Weijuan Li, Fengmei Guo, who have given me great help 
and support during my study. I am also very grateful to Xiongfei Huang, Yongsheng Ye in the 
orthopedic ward, who took constant efforts to this project. 
 
At last, special appreciation, of course, should go to my father Mr. Xiaohao Wang and my mother 
Ms. Anna Qi for great understanding, encouragement, and all the financial support to cover my 
two-year master study in Oslo.  
 
 
V 
 
Abstract 
Surgical Site Infection after Orthopedic Surgery Performed in Dong Guan Hospital of 
Traditional Chinese Medicine: A Descriptive Study of the Burden of Surgical Site 
Infection and its Risk factors with A Focus on Antimicrobial Prophylaxis and 
Traditional Chinese Medicine in Spinal Surgery 
 
Background: Surgical site infection (SSI) is a serious complication after orthopedic surgery, and it 
is associated with high morbidity rates, high healthcare costs and in some cases poor patients’ 
outcomes.  
Aims: The purpose of this study was to identify the burden of SSI among orthopedic surgery and its 
associated risk factors of SSI among the people underwent spinal surgery in a selected hospital in 
China.  
Methods: From June 26 to November 30 in 2014, we performed a prospective surveillance study in 
the patients who underwent orthopedic surgery in a selected Chinese hospital. SSI was diagnosed 
based on the definition established by the Centers for Disease Control and Prevention (CDC) and 
was identified by bedside surveillance and post-discharge checkup. Detailed pre-, intra-, 
post-operative patient characteristics were prospectively recorded using a standardized data 
collection format.  
Results: A total of 287 orthopedic surgery cases, among them 192 cases of spinal surgery, were 
included, of which 8 cases developed surgical site infection. Wound contamination class, wound 
drains and blood transfusion were surgery-related risk factors for orthopedic spinal surgery during 
the hospital stay after bivariate analysis. Intravenous AMP was given in 176 of 287 (61.3%) after 
orthopedic surgery. The average duration of AMP administration was 2.2 days (range 1-9 days).  
Conclusion: In conclusion, we identified an incidence proportion of SSI after orthopedic surgery of 
2.8%. The orthopedic SSI risk factors (wound contamination class, wound drains and blood 
transfusion) identified in present study may use to be reducing the incidence of SSI in the future. 
VI 
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WHO World Health Organization 
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Surgical Site Infection after Orthopedic Surgery Performed in Dong Guan 
Hospital of Traditional Chinese Medicine: A Descriptive Study of the Burden 
of Surgical Site Infection and its Risk factors with A Focus on Antimicrobial 
Prophylaxis and Traditional Chinese Medicine in Spinal Surgery 
1 Introduction 
Healthcare-Associated Infections (HAIs) are infections that patients acquire while receiving 
medical care, and are one of the most frequent adverse events during care delivery [1]. HAI is a 
major problem for healthcare safety and can result in prolonged hospital staying, additional 
therapies, financial burdens, and even mortalities [2, 3]. Consequently, HAI control has been 
gradually receiving more public attention, with implementing effective practices such as 
surveillance to minimize the risk of infection and assure the patients’ safety [4]. 
 
1.1 Burden of endemic healthcare-associated infections 
World Health Organization (WHO) report [5] from 2011 showed that the prevalence of HAI in low- 
and middle-income countries from 1995-2010 ranged from 5.7% to 19.1%[5], while this prevalence 
of HAI was significantly higher in high-income counties ranged from 3.6 to 12.0%. Stoesser et al.[6] 
showed that the overall HAI prevalence in a Cambodian study in 2013 was 13.8%. Kumar et al.[7] 
showed that the overall prevalence of HAIs in an Indian study in 2014 was 7%. Thu et al.[8] 
showed that the prevalence of HAIs in a Vietnamese study in 2011 was 7.8%. From review articles 
based on pre-studies [9-11] in China, it showed that the prevalence of HAI in all of China decreased 
from 5.2% in 2001 to 3.2% in 2012. A WHO report[5] discussed that the HAI surveillance in 
developing countries was a highly demanding task, and thereby only 23 of 147 developing countries 
reported a functioning national surveillance system of HAI.  
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• Developed countries  
• Developing countries 
• China 
Figure 1 Trends of the point prevalence of Healthcare-Associated Infections in China 2001-2012 
 
 
1.2 Burden and consequences of surgical site infection 
Surgical site infection (SSI) is a serious complication after orthopedic surgery, and it is associated 
with high morbidity rates, high healthcare costs and in some cases poor patients’ outcomes[12]. SSI 
is reported to be the third most common HAI in Europe, U.S. and China [10, 13-15] 
  
Figure 2 Incidence of surgical site infection in several countries around the world 2001-2012 
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A systematic review published in U.S. in 2013 by Korol et al.[16] showed that the median SSI 
incidence was 3.7%, ranging from 0.1% to 50.4%. An estimation based on European study in 
2004[17] indicated that SSI can increase medical economic costs for hospital and health insurance 
companies, ranging from 1.5 to 19.1 billion Euro dollars per year.  
 
The magnitude of the burden of orthopedic SSI varies between different studies and different parts 
of the world by the type of orthopedic surgery performed. The overall incidence of orthopedic SSI 
reported from Monmouth Medical Center in U.S. between 2003 and 2007 [18] ranged from 0.8% 
for open reduction of fracture to 1.0% for a spinal fusion. From the European Centre for Disease 
Prevention and Control (ECDC) report 2008-2009[14], the cumulative incidence of SSI was 1.2% 
for hip prosthesis, and 0.8% for knee prosthesis, and 1.3% for laminectomy. Caputo et al.[19] 
showed that 3.7% of the orthopedic cases developed a SSI after spinal procedures at Duke 
University Medical Center in U.S. between 2005 and 2010. Mackenzie et al [20]showed the overall 
incident rate of SSI among pediatric patients undergoing spinal instrumentation to correct scoliosis 
was 5.8% in three children's hospitals in U.S. between 2006 and 2008. Kakimaru et al. [21] showed 
that the incidence of SSI among patients who underwent spinal surgery was 2.1% in Japan between 
2003 and 2009. Lee et al [22] reported that patients with SSI have a higher rate of complication, and 
the SSI was a strong predictor of mortality (OR=3.8; 95% CI=1.5-9.7) after orthopedic surgeries. 
 
Though retrieving on available literatures in China National Knowledge Infrastructure, it was 
identified that the incidence of SSI among patients with spinal surgery ranged from 1.8% to 7.7% 
across the country [23-25]. According the Guideline of Hospital Management and Assessment[26] 
published by Ministry of Health in China, the goal is that the overall incidence proportion of SSI 
after clean surgeries should be≤1.5%. As seen below the published results are based on different 
type of orthopedic surgeries and are from different part of China. 
 
Anhua et al.[9] showed in a national survey performed in China that the overall incidence of 
orthopedic SSI in 2012 was 2.8%. Qunjie et al.[27] showed that the incidence proportion of SSI 
after total hip arthroplasty (THA) was 2.2% in a selected hospital in Beijing in 2010. Zhangjia et al. 
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[28] showed that the incidence proportion of SSI after THA was 5.2% in Southern China in 2011. 
Nie et al. [23] showed in the study conducted at Capital Medical University in Beijing between  
2004 and 2009 that 7.7% cases experienced postoperative infectious complication after spinal 
surgery. Haili et al. [24] found in the study conducted at Wenzhou Medical College between 2009 
and 2012, an SSI proportion was 4.4% among patients undergoing spinal surgery. Qingsong et al. 
[25] showed in the retrospective study conducted at Southern Medical University China between 
2010 and 2013 that the overall incident proportion of SSI among patients undergoing spinal surgery 
was 1.8%.  
 
Figure 3 Incidence of surgical site infection based on different type of orthopedic surgeries 
and from different parts of China 
 
 
1.3 Surgical site infection detected in post-hospital discharge surveillance 
According to the Centers for Disease Control and Prevention (CDC) criteria SSI can occur up to 30 
days (1 year if an implant is inserted) after surgery. The proportion of SSI identified after discharge 
varies by studies. Kent et al. [29] showed in the study conducted at St John of God Health Care 
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Australia between 1996 and 1998 that the rate of SSI in post-discharge surveillance (PDS) (6.0%) 
was more than double that in hospital (2.7%). Rosenthal et al.[30] showed in the study conducted at 
the University Hospital Basel Switzerland between 2000 and 2001 that the overall SSI rate was 
4.7%, among from which 63.8% were detected in-hospital and 36.2% after discharge. Reilly et al. 
[31] showed in the Scottish Surveillance of Healthcare-Associated Infection Program between 2002 
and 2004 that the SSI rate among the operations with no PDS was 2.61%, which was significantly 
lower than the SSI rate was 6.34% among the operations with PDS performed.  
 
1.4 Risk factors of surgical site infection after spinal surgery 
The incidence of SSI after spinal surgery could be influenced by patients’ characteristics and pre-, 
intra- and post-operative factors. Following factors are shown to increase the risk of developing a 
spinal SSI: trauma, elder age, malnutrition, skin preparation not being performed, American Society 
of Anesthesiologists (ASA) score≥3, inappropriate timing of prophylactic antibiotic therapy, 
duration of surgical procedure≥3h, wound classified as contaminated or dirty, instrumentation, 
intraoperative blood loss, intraoperative blood transfusion, use of wound drains, and length of stays 
[13, 32-34]. However, a systematic review[32] indicated that there is a paucity of solid evidence of 
robust risk factors associated with spinal surgery. 
 
1.5 Prophylactic antimicrobial of administration  
Surgical Antimicrobial Prophylaxis (AMP) is designed for achieving effective antimicrobials 
concentration at the time of initial surgical incision, and maintained throughout the period of the 
procedures[35]. AMP administered properly is shown to reduce the incidence of SSI for 
patients[35]. The American Society of Health-System Pharmacists Therapeutic Guidelines[36] 
shows that AMP is not recommended for patients undergoing clean orthopedic procedures, 
including knee, hand, and food procedures, arthroscopy, and other procedures without 
instrumentation or implantation of foreign materials; while AMP is recommended for orthopedic 
spinal procedures with and without instrumentation. However, “Principle Guideline for 
Antimicrobials Clinical Use”[37] in China shows that AMP is not recommended in general, except 
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high risk factors, such as total hip arthroplasty, total knee arthroplasty, instrumentation and other 
factors. A review article[38] reported that the Ministry of Health in China issued a series of rules 
and regulations and guidelines. Most of them were general principles but not operational details. 
Through retrieving guidelines in Chinese database, there is no clear recommendation that AMP 
should be used for orthopedic spinal procedures in China. 
 
In addition, according to “Principles and guidelines for clinical applications of prophylactic 
antibiotics” published by the Ministry of Health in China in 2004[39, 40], the general principle is 
that a single dose should be given in clean surgery less than 2 hour, and second dose should be 
given when surgery lasts more than 3 hour or blood loss exceeds 1,500 ml. The duration of 
prophylaxis should be less than 24 hours [38].  
 
1.6 Microorganism of orthopedic surgeries 
For most orthopedic SSI, the sources of pathogens are from the patients’ own flora. Exogenous 
sources of SSI pathogens arise from surgical personnel, the operation-room environment, 
instrumentations and materials brought to the sterile field. Mackenzie et al [20] showed in a 
retrospective study from multicenter in U.S. from 2006-2008 that the three most common pathogens 
in spinal surgeries were staphylococcus aureus, coagulase-negative staphylococci and 
Pseudomonas aeruginosa. Antibiotic resistance has become more common and some studies [41, 
42] have showed that methicillin-resistant Staphylococcus aureus (MRSA) is the most common 
organism in orthopedic SSI. A study [43] has shown that among 35 bacterial strains isolated after 
orthopedic surgery, 65.7% were gram-positive isolates, and 34.3% were gram-negative bacteria; 
68.6% of all bacterial isolates were resistant to cefuroxime after orthopedic surgery.  
 
2 Rationale of the study 
A surveillance system is a method for understanding the incidence and distribution of SSI [44]. In 
China, public reports of SSI, obtained via ongoing national surveillance activities, have been rare 
over the past decades [45]. The computerized search strategy resulted in 33 citations in the last five 
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years by the key words “Spinal”, “Surgical site infection” and “China” into the PubMed (English) 
search engine. This indicates a paucity of quantitative research regarding the burden and associated 
risk factors of SSI among the people with orthopedic surgeries in Dong Guan community as well as 
in China. Most of the articles from China published in PubMed were description of clinical therapy 
and clinical trial research on orthopedic surgery, and not included SSI. The focus on orthopedic SSI 
in Dong Guan community has just started and the resources for orthopedic SSI-control have been 
insufficient. Given this situation, the president of the hospital and the dean of the department of 
HAI-control wanted and had permitted this collaboration research. The goal of this study was to fill 
the knowledge gaps of HAI-control in this hospital, and it could contribute to the reduction of the 
occurrence of SSI. 
 
Another rationale for this study was that the search in PubMed showed no literatures of quantitative 
study discussing the use of traditional Chinese medicine (TCM). The only findings about TCM 
(such as Panax notoginseng saponins)[46] showed that they not only have immunomodulatory and 
antimicrobial effects, but also have biological effects on anti-inflammatory, promoting circulation 
and supporting tissue/bone healing[47, 48]. This project aims to fill this knowledge gap, by 
discussing the use of TCM. 
 
The literatures [32] on SSI following spinal surgery shows that a total of 73 different types of 
factors were evaluated as risk factors of SSI but it was still stated a need for more researches[32]. 
This project was built upon the existing surveillance system, but it also included additional 
variables referred by CDC and studied articles [23, 49-53]. A goal of this project was to examine the 
effect of different types of risk factors of orthopedic SSI following spinal surgery emerging during 
the pre-, intra- and post-operation in the hospital setting, in order to target specific risk factors. 
 
3 Objectives and research questions 
Overall objective 
To identify the burden of SSI in orthopedic surgery and its associated risk factors among the people 
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undergoing spinal surgery in Dong Guan Hospital of Traditional Chinese Medicine in China 
between June 26 and November 30 in 2014. 
Specific aims 
• To identify the total incidence proportion of SSI at the time of hospital discharge as well as 30 
days post-surgery. 
• To identify the total incidence proportion of SSI by type of orthopedic surgery. 
• To identify the most common micro-organisms associated with orthopedic SSIs as well as their 
antimicrobial susceptibility patterns. 
• To identify possible risk factors of SSI after spinal surgery 
•To explore the use and possible associations of AMP and TCM on the rate of SSI. 
 
4 Materials and methods 
4.1 Brief description of the study site 
Dong Guan City is located in the southern China and adjoined to Hong Kong. It is a relatively 
developed region with abundant healthcare resources in China, with a total Gross Domestic 
Product(GDP) of 473.5 billion CNY (approximately 76 billion USD) in 2011 and its GDP per capita 
of 9,190 USD[54] (compared with 100,818 USD GDP per capita in Norway in 2013 [55]). The 
publications from the Health Bureau of Dong Guan City [56] showed that by 2010 the average life 
expectancy of the city will exceed 77 years. The infant mortality rate is below 10 deaths/1,000 live 
births (<11deaths/1,000 live births in China).  
 
In 2005, the total expenditure on health service reached 285.9 million CNY (45.8 million USD), 
accounting for 2.0% of the financial budget [56]. It was estimated that in 2010 in Dong Guan City 
the ratio of doctors to nurses was1:1.2. The ratio of available beds against clinical doctors was 1:0.4 
with the ration for ICU reaching 1:2.5-3. The number of practicing (assistant) doctors, registered 
nurses and hospital beds by thousand people was 1.7, 2.0 and 3.1 respectively.  
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The Health Bureau of Dong Guan City recommended healthcare providers and healthcare-settings 
to undertake tasks of HAI-control and surveillance, improve outbreak surveillance system and 
pre-warning system, and strengthen the construction of professional teams which are focusing on 
upgrading the capability of investigation about epidemic diseases[56]. 
 
Figure 4 Geographical location of Dong Guan City in China 
 
 
4.2 Dong Guan Hospital of Traditional Chinese Medicine and its surveillance and 
infectious control program 
The Dong Guan Hospital of Traditional Chinese Medicine is a tertiary hospital, with an integrated 
function of medical treatment, teaching and research, with 955 hospital-beds. According to 
“Nosocomial Infectious Control Measurement”[57] published by the Central People’s Government 
of the People’s Republic of China in 2006, a Hospital Infectious Control Committee has been 
established. Its responsibility is HAI-control training and meeting with infectious control 
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practitioners, infectious information feedbacks, and identification and management of 
HAI-outbreak. According to “Standard for nosocomial infection surveillance WS/T312-2009” [58] 
published by the Health Industry Standard of the People's Republic of China in 2009, the Dong 
Guan Hospital of Traditional Chinese Medicine has established a prospective surveillance system of 
orthopedic SSI[59].  
 
4.3 Traditional Chinese Medicine used in Dong Guan Hospital of Traditional 
Chinese Medicine 
Development of TCM is based on the concept of Yin and Yang. These opposing and complementary 
natural phenomena of the universe restore the normal physiological functions, consequently curing 
diseases and restoring health of a patient[60]. Surgeons and physicians in the Dong Guan Hospital 
of Traditional Chinese Medicine usually use an integrated clinical treatment/integrative practice. 
According to the clinical condition of the patients, surgeons with TCM background choose selected 
herbs as supplementary treatment to enhance the efficacy of western medicine, with inhibiting 
effect on the inflammatory responses, promoting blood circulation, and removing the swelling [46, 
61, 62]. According to property of TCM, patients are treated with TCM in a highly individualistic 
way, recognizing that not two patients are alike. However, the therapy is not strictly evidence-based 
because of lacking enough clinical studies [63]. 
 
4.4 Rationale for the choice of research method  
The systematic review showed that different methodologies[64] were used in orthopedic SSI 
surveillance. It is recommended to use prospective cohort study to detect orthopedic SSI[65]. The 
advantage of this study-method is that it provides the reliable and less biased datasets by applying 
daily observation, and it allows you to identify possible associated risk factors for orthopedic SSI. 
Potential disadvantage is that prospective surveillance is more time-consuming and that a large 
sample size is required to identify associated risk factors. However, the case-control design and 
cross-sectional method is not recommended in the orthopedic SSI surveillance system, due to the 
limitations that they cannot be used to the incidence proportion of orthopedic SSI[65]. 
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Cross-sectional study is not suitable to use to identify associated risk factors[65]. 
 
4.5 Research design 
The study was conducted as a prospective cohort study focusing on patients undergoing orthopedic 
surgery in the Dong Guan Hospital of Traditional Chinese Medicine, affiliated to Guangzhou 
University of Chinese Medicine between June 26 and November 30 in 2014. 
 
4.6 Study population 
The study included all patients in the Dong Guan Hospital of Traditional Chinese Medicine who 
undergoing orthopedic surgeries at an orthopedic surgery ward between June 26 and November 30 
in 2014. No patients were excluded from this study. 
 
4.7 Sample size calculation 
In the study, we would have been conducted as a prospective cohort study focusing on all the 
patients undergoing orthopedic surgery at an orthopedic ward in the hospital. The initial design used 
an estimate of the incidence of orthopedic SSI[66] approximately ranged from 1.8% to 7.7% 
according to literature review. In order to detect an orthopedic SSI, with an assumed odds ratio of 
5.8 and a prevalence of 2%, we need a sample of 244 cases to achieve a power of 80%.  
 
4.8 Definition of surgical site infection 
All SSI-cases are defined according to the CDC-criteria for SSI diagnosis (Annex 1)[67], and SSI 
are classified as incisional or organ/space. Incisional SSIs are divided further into superficial 
incisional SSI or Deep superficial SSI [65, 67].  
 
4.9 The preparation of the study 
The surveillance was conducted by personnel in the Department of HAI-control and personnel in an 
orthopedic ward. Even though this project was in accordance with the ongoing surveillance system, 
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the investigator (the author of this thesis) developed a protocol (See Research Protocol) and specific 
questionnaire including more potential risk factors and PDS (Annex 9 and 10). The permission to 
conduct the study was needed and given by both the dean of the department of orthopedics and the 
president of the hospital.  
 
4.10 Sources of information 
The sources of information in this study was from hospital records, medical records, medical 
progress notes records, procedure-related records, anesthesia record sheets and surgical risk 
assessment form. These datasets were captured from Hospital Informatics Systems.   
 
Figure 5 Hospital Informatics Systems in the Dong Guan Hospital of Traditional Chinese Medicine 
 
 
4.11 Surgical site infection registration 
If a patient who had two operations more than thirty days apart each operation was recorded 
independently of each other. If the second operation was a result of SSI it was recorded as a 
consequence of the SSI. If re-operated for reasons other than SSI, the total number of operations 
within thirty days was recorded as a potential risk factor. The patient was followed up thirty days 
after the first operation. 
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4.12 Data collection and case finding 
In the hospital, identification of potential SSI was done by the examination of the patient medical 
records, microbiology reports, nursing notes, International Classification of Diseases, Ninth 
Revision codes, and antimicrobials used. The investigator performed actively bed-side observation 
three days a week (Monday, Wednesday and Friday). The wounds of those patients that had 
prescribed antimicrobials, had a temperature over 37 Degree Celsius or relevant co-morbidity that 
easily caused SSI was examined.  
 
Surgeons daily visited the patients with orthopedic surgeries, reviewed their medical records and 
supervised the wounds. The questionnaires (Annex 9) were filled by surgeons and thereafter 
reported to the department of HAI-control, if a SSI was identified. In addition, clinical pharmacists 
reported actively the suspected-SSI with irrational antimicrobials prescription to surgeons and 
investigator.   
 
During the hospital stay, some patients with co-morbidities such as heart diseases, diabetes mellitus 
could be transferred to other wards for further medical treatment. The main investigator continued 
to follow these patients until 30 days after surgery and filled in questionnaire (Annex 9) before 
discharge. 
 
4.13 Post-discharge surveillance and case finding 
Phone call 
According to the CDC-criteria, the SSIs might occur up to 30 days post-surgery. The investigator 
would follow up the patients via telephone interview using a pre-defined script of questionnaire for 
the detection of SSI. During the interview the investigator asked the patients with questions (Annex 
10) and the answers only documented by “YES” or ”NO” to evaluate the wound status of patients. 
Before the interview, oral informed consent would be obtained. 
 
Post-discharge examination checkup 
All the patients received an appointment for a post-discharge examination at the out-patient clinic 
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but it was not mandatory. The investigator also participated on the out-patients clinical round during 
changing the wound dressings, with examination of the incisional sites for pain, redness, warmth, 
swelling and purulent drainage. However, it was found to be difficult for the investigator to follow 
up those patients who did not attend the post-discharge checkup.  
 
Readmission 
The surgeons would have been asked by investigator to actively report the post-discharge infections 
being detected at outpatient clinic, if the patients readmitted for surgery were surveyed for 
infections.   
 
4.14 Microorganism   
For the bacteria isolation, specimens were inoculated onto blood agar plates, incubated in an aerobic 
chamber at 37°C, and examined at 48 and 96 hours. Laboratory technicians trained the surgeons in 
how to acquire the appropriate sample from the surgical site, and stress the use of asepsis technique. 
Laboratory technicians informed the surgeons and the investigator of confirmation of positive 
microorganism, even Multidrug-Resistant Organisms [68]. 
 
4.15 Included variables and data handling 
This project included all variables (Annex 6) which were already in the hospital surveillance system 
such as age, gender, ASA scores, wound contamination class, duration of surgical procedures, type 
and duration of AMP administrated; as well as risk factors referred by CDC and identified by 
studied articles [23, 49-53], such as BMI, diabetes mellitus, rheumatoid arthritis, bone oncology, 
type of anesthesia, pre-operative stay, instrumentations, skin-preparation, number of participants 
attending to the orthopedic surgeries, intraoperative blood loss, wound drains, duration of wound 
drainage, intraoperative blood transfusion, TCM administrated, white blood cell count before/after 
surgery, bacteria isolation and length of stays. 
 
All data was electronically recorded and thereafter transferred to the department of HAI-control. 
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The investigator translated information into English, and then filled out the study data-form. All 
data was entered into a Microsoft Excel2010 file. 
 
4.16 Data validation 
The investigator and his colleagues in the department of HAI-control were responsibility for the 
data validation. All the questionnaires (Annex 9) were validated against information recorded in the 
patient’s medical file to assure that all the correct data was being filled in. If some datasets were 
incorrect or missing information, the surgeons would be asked to fill in and correct them. A SSI 
case was confirmed and ensured the agreement between the surgeons and investigator. If diagnosis 
of a SSI-case was disagreed by both, the investigator would judge and diagnose a SSI-case 
according to CDC-criteria (Annex 1). 
 
4.17 Training 
All the staffs included in this surveillance were trained by the investigator one week before the 
project started. Training included information about the data collection methods as well as the 
principle of diagnosis of SSIs according to CDC-criteria (Annex 1). A key emphasis was that all the 
needed information in the questionnaire (Annex 9) should be filled in, and it should be assured that 
the datasets were authentic and correct. This surveillance system of SSI has been conducted since 
2008 in this hospital. We therefore regarded it as unnecessary to perform a pilot-testing to test and 
refine the survey methods. 
 
5 Statistical analysis 
The datasets were analyzed using IBM SPSS Statistics Software Version 22.0. Descriptive statistical 
analysis was run. Mean, 95% confidence interval (Cl), minimum and maximum of each continuous 
variable was calculated.   
 
Only spinal procedures were included in risk factors analysis knowing that this was the most 
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common procedures in this study. Patient’s characteristics related to SSI were compared by using 
Chi-square test or Fisher’s exact test for categorical variables and the by using Wilcoxon test for 
continuous variables. Associations between SSI and possible risk factor were analyzed by 
calculating crude Odd’s Ratio (OR) using Bivariate Logistic Regression Analysis.  
 
6 Ethical considerations 
Ethical clearance was obtained both from “Regionale Komiteer for Medisinsk og Helsefaglig 
Forskningsetikk” from Norway and Ethics Committee from the Dong Guan Hospital of Traditional 
Chinese Medicine (Annex 11,12 and 13). The questionnaires (Annex 9 and 10) were locked and 
kept securely by the project leader. Participants were anonymous in the questionnaire. Only the 
investigator and his colleagues had an access to review and manage these datasets. 
 
This study was regard as a quality assurance project and was therefore unnecessary to obtain 
informed consent from the each patient. Only information already documented in patient file was 
included in this project, with the exception of the 30 days following up by phone.  
 
Our project did not provide intervention and did not include any harm for the patients. When 
contacting patients by phone after hospital discharge, we informed them about the project and they 
could choose not to answer to questions regarding SSI-study. 
 
7 Results 
7.1 General description and demographical data  
All 287 patients that had orthopedic surgeries between 26 June and 30 November in 2014 were 
included in the study. There were 165 females (57.5%) and 122 males (42.5%). The mean age was 
54.2 years (range, 9-89 years), and it was higher among women than men (60.7 years VS 45.4 
years). The age as continuous variable followed a normal distribution (Figure 6). 
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Figure 6 Normal distribution in Age 
    
 
The mean days of pre-operative stay was 6.6 days (range, 1-33 days). The mean total days of 
hospital stay was 16.8 days (range, 4-77). The mean duration of surgery was 116.3 minutes (range, 
20-575). More demographical characteristics are found in Table 1. 
 
Among the 287 orthopedic surgeries, 67 (23.3%) patients had hypertension, 23 (8.0%) patients had 
diabetes mellitus, 11 (3.8%) patients had rheumatoid arthritis, 23 (8.0%) patients had bone oncology, 
114 (39.7%) patients had wound drainage, and 28 (9.8%) patients had intraoperative blood 
transfusion. 
 
The most common procedures performed in this orthopedic ward were spinal surgery with 192 
cases (66.9%), followed by clavicular surgery (5.2%), tibia surgery (5.2%), and anklebone surgery 
(4.2%). According to categorization of ICD-9-CM codes, the three most common spinal surgery 
procedures in the present study were vertebroplasty (51.0%), spinal decompression (14.6%), and 
spinal fusions (7.3%).   
 
7.2 Surgical site infection detected during in-hospital and post-discharge 
Among the 287 orthopedic surgeries, 8 (2.8%) patients developed SSI. All SSIs were detected 
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among in-hospital patients and no SSI was detected by PDS. According to the CDC definition, 4 
(1.4%) of infections were superficial incisional SSI, 4 (1.4%) of infections were deep Incisional SSI 
and no case was diagnosed with Organ/Space SSI (Table 1). In addition, among the 192 orthopedic 
spinal surgeries, 7 (3.6%) patients developed SSI after spinal surgery, with 3 (1.6%) patients of 
superficial incisional SSI and 4 (2.1%) patients of deep incisional SSI.  
 
7.3 Risk factors for spinal surgery 
Bivariate analysis indicated several significant risk factors, including wound contamination class 
(OR, 45.5; 95% Cl, 6.9-298.8), wound drains (OR, 8.8; 95% Cl, 1.0-74.6), blood transfusion (OR, 
5.6; 95% Cl, 1.2-26.5) (Table 4). 
 
7.4 Routines of antimicrobial prophylaxis and traditional Chinese medicine 
Intravenous AMP was given in 176 of the 287 (61.3%) after orthopedic surgeries. In addition, 34 
other cases received antimicrobials treatment at the time of surgery. 174 of 176 (98.9%) received 
AMP within 2 hours before the orthopedic procedures. The average duration of AMP administrated 
was 2.2 days (range 1-9 days) (Table 2). In addition, intravenous AMP was given in 120 of the 192 
(62.5%) after orthopedic spinal surgeries.  
 
The four most common AMP prescribed were cefotiam (35.8%), cefathiamidine (22.2%), 
cefuroxime (17.6%) and cefamandole (9.1%) (Table 2). These four prescriptions contributed to 84.7% 
of the total AMP given. All the 8 patients who developed SSI did receive AMP.  
 
TCM was prescribed to 219 of the 287 patients (76.3%). The three most common TCM deliveries in 
the present study were Panax notoginseng saponins (55.7%), Salvia miltiorrhiza (23.7%), and 
Lumbricus rubellus (11.9%) (Table 3). More specific functions of common TCM are found in 
Annex 8. 
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7.5 Microorganism 
Among the 8 patients developed SSI, only 4 patients had performed wound bacterial culture. 2 of 4 
SSIs were examined and identified microorganisms, among one case being documented as 
Multi-Drug Resistant Organism [E.coli + Extended-Spectrum Beta-Lactamases (ESBLs)] (Table 6). 
It was resisted towards 69.6% of the available antimicrobials in this hospital. 
 
Table 1 General description and demographical information for patients undergoing orthopedic 
surgery at Dong Guan Hospital of Traditional Chinese Medicine in China during 26 June to 30 
November in 2014 
Patient’s characteristics  All orthopedic surgery 
The total number of procedures (cases) 287 
Male ( % ) 122 (42.5%) 
Female ( % ) 165 (57.5%) 
Mean age in years (range) 54.2 (9-89) 
Mean days of pre-operative stay (range) 6.6 (1-33) 
Mean total days of hospital stay (range) 16.8 (4-77) 
Mean duration of surgery in minutes (range) 116.3 (20-575) 
The number of SSI 
a
 ( % ) 8 (2.8%) 
b
 
The number of Superficial SSI
 a
 ( % ) 4 (1.4%) 
c
 
The number of Deep SSI
 a
 ( % ) 4 (1.4%) 
d
 
The number of SSI
 a
 diagnosed in-hospital ( % ) 8 (2.8%) 
 
a
  SSI: Surgical Site Infection 
 
b  
7 of them were after orthopedic spinal surgery 
 c  
3 of them were after orthopedic spinal surgery 
 d 
 All of them were after orthopedic spinal surgery 
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Table 2 Descriptive analysis of AMP among all the orthopedic surgery at Dong Guan Hospital of 
Traditional Chinese Medicine in China during 26 June to 30 November in 2014 (N=287) 
Patient’s characters All orthopedic surgery 
AMP administrated ( % ) 176 (61.3%) 
AMT administrated ( % ) 34 (11.8%) 
AMP deliveries given within 2 hours  
before the orthopedic surgery ( % ) 
174 (98.9%) 
Mean of duration of AMP deliveries in day (range) 2.2 (1-9) 
The type of AMP ( % ) - 
cefotiam 63 (35.8%) 
cefathiamidine 39 (22.2%) 
cefuroxime 31 (17.6%) 
cefamandole 16 (9.1%) 
cefoxitin 9 (5.1%) 
*AMP: antimicrobials prophylaxis; AMT: antimicrobials treatment 
 
Table 3 Descriptive analysis of TCM among all the orthopedic surgery at Dong Guan Hospital of 
Traditional Chinese Medicine in China during 26 June to 30 November in 2014 (N=287) 
The type of constituents of TCM All orthopedic surgery 
TCM deliveries ( % ) 219 (76.3%) 
Panax notoginseng saponins 122 (55.7%) 
Salvia miltiorrhiza 52 (23.7%) 
Lumbricus rubellus 26 (11.9%) 
*TCM: traditional Chinese medicine 
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Table 4 Risk factors of SSI among patients undergoing spinal surgery at Dong Guan Hospital of 
Traditional Chinese Medicine in China during 26 June to 30 November in 2014 (N=192) 
Patients characteristics 
(Variables) 
Total number patients 
of operations 
(SSI case) 
Odds ratio (95% Cl) 
Bivariate analysis 
Age 
Age≤62yrs 105 (5) Reference Cat. 
Age>62yrs 87 (2) 0.5 (0.1-2.5) 
Gender 
Female 130 (5) Reference Cat. 
Male 62 (2) 0.8 (0.2-4.4) 
Body Mass Index (BMI) 
BMI≤25 119 (6) Reference Cat. 
BMI>25 15 (1) 1.3 (0.2-12.0) 
Missing 58 (0) - 
Rheumatoid arthritis 
Yes 7 (1) 5.0 (0.5-48.0) 
No 185 (6) Reference Cat. 
Pre-operative stay 
≤7 Days 140 (5) Reference Cat. 
>7 Days 52 (2) 1.1 (0.2-5.7) 
Orthopedic 
instrumentation 
Yes 60 (4) 3.1 (0.7-14.2) 
No 132 (3) Reference Cat. 
American Society of 
Anesthesiologists 
(ASA) scores 
1+2 165 (5) Reference Cat. 
3 27 (2) 2.6 (0.5-13.9) 
Wound 
contamination 
class 
Class 1+2 186 (4) Reference Cat. 
Class 3+4 6 (3) 45.5 (6.9-298.8) 
Skin preparation 
Yes 167 (6) Reference Cat. 
No 25 (1) 1.1 (0.1-9.7) 
The duration of operation 
<3h 146 (5) Reference Cat. 
≥3h 46 (2) 1.3 (0.2-6.8) 
The number of 
participants in the 
orthopedic surgery 
3-5 participants 122 (2) Reference Cat. 
6-9 participants 70 (5) 4.6 (0.9-24.5) 
Intraoperative <500ml 162 (4) Reference Cat. 
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blood loss >500ml 30 (3) 4.4 (0.9-20.7) 
Wound drains 
Yes 81 (6) 8.8 (1.0-74.6) 
No 111 (1) Reference Cat. 
Blood transfusion 
Yes 25 (3) 5.6 (1.2-26.5) 
No 167 (4) Reference Cat. 
WBC before surgery 
4-11×10
9
/L 158 (5) Reference Cat. 
>11×10
9
/L 34 (2) 1.9 (0.4-10.3) 
WBC after surgery 
4-11×10
9
/L 106 (3) Reference Cat. 
>11×10
9
/L 49 (3) 2.2 (0.4-11.5) 
Missing 37 (1) - 
AMP deliveries 
Yes 120 (7) Reference Cat. 
No 72 (0) - 
The duration of AMP 
deliveries 
NO-AMP 72 (0) - 
≤1day 48 (3) Reference Cat. 
>1day 72 (4) 0.9 (0.2-4.1) 
TCM deliveries 
Yes 139 (4) Reference Cat. 
No 53 (3) 2.0 (0.4-9.4) 
 
Table 5 Demographic characteristics of patients undergoing spinal surgery at Dong Guan Hospital 
of Traditional Chinese Medicine in China during 26 June to 30 November in 2014 (N=192)  
Characteristics  SSI(N=7) Non-SSI(N=185) P-value* 
Age at surgery, mean(SD), year 60.3(15.5) 61.8(14.7) 0.553 
BMI, mean (SD), kg/m
2
 23.6(2.8) 23.1(2.7) 0.273 
Duration of operation, mean (SD),minutes 167.1(103.3) 122.5(102.8) 0.499 
Total amount of drainage, mean (SD), ml 399.2(307.1) 258.5(185.1) 0.180 
*Wilcoxon test was used for continuous variables 
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Table 6 Microbiologic characteristics of orthopedic SSI at Dong Guan Hospital of Traditional 
Chinese Medicine in China during 26 June to 30 November in 2014 (N=4) 
Microorganism(s) No. of cases 
Escherichia coli + ESBLs 1 
Enterobacter cloacae 1 
Negative 2 
Total 4 
* ESBLs: Extended-spectrum beta-lactamases, SSI: Surgical site infection 
 
8 Discussions 
8.1 Incidence proportion of surgical site infection 
This study has identified that an incidence proportion of SSI after orthopedic surgery was 2.8% 
(8/287), from which 3.6% (7/192) developed SSI after spinal surgery in an orthopedic ward of 
Dong Guan Hospital of Traditional Chinese Medicine. 
 
The incidence of orthopedic SSI identified in this study was comparable to the statistical figures 
from Chinese national survey[9], but was slightly higher than the figures from ECDC report[15]. 
We also found that the incidence of spinal orthopedic SSI was slightly higher compared with other 
types of orthopedic SSI. This finding is consistent with what’s reported in the literatures [13, 15]. 
 
We suspect that the incidence proportion of SSI identified by this study might be underestimated 
due to no SSI being detected by PDS. Other studies showed that 1.7%-3.3% of SSIs were detected 
by PDS [29, 30, 69-71].   
 
A possible explanation for no SSIs being detected during post-discharge was a low attendance at the 
out-patients clinic for examination of incisional sites. Some patients are living far away from the 
Dong Guan Hospital of Traditional Chinese Medicine. They might have attended to a hospital 
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nearby them for checkup or readmission. There was no system that synchronized information 
enables us to identify SSI among patients in other hospital. 
 
In our study, 72.5% cases completed the phone-interview during post-discharge. The mean age was 
higher among patients not-interviewed by phone than those being interviewed (59.1 years VS 52.3 
years). It is known that elder people had a risk of SSI [32]. It might be that they were SSIs among 
those not being interviewed.  
 
8.2 Risk factors for spinal surgery 
Wound contamination class, wound drains, and blood transfusion were associated with the 
occurrence of spinal orthopedic SSI in the bivariate analysis. These risk factors are also reported by 
others [13, 32-34, 72, 73]. Others have identified ASA scores, instrumentation, duration of surgical 
procedure≥3h, longer duration of AMP administrated to be association with SSI after spinal 
surgery. However, in our study, these factors were not associated with SSI. A possible explanation is 
that the present study was underpowered and therefore unable to identify association between SSI 
and some variables.  
 
In this study, wound contamination class as a risk factor has association with the occurrence of 
orthopedic spinal SSI. This finding was consistent with previous studied article [71]. Wound drains 
were risk factor for orthopedic spinal SSI. This result is consistent with published studies [73, 74]. 
The longer the drains remained in place, the higher the risk of postoperative wound infection. 
Drains may increase the risk of infection by causing local tissue inflammation and/or providing 
direct access to the surgical site for bacteria by ascending the drain tract [73, 75, 76]. Blood 
transfusion as a risk factors has association with infection after orthopedic spinal surgery, which is 
consistent with the article published by Ho et al [77]. Blood transfusion recipients were more 
susceptible to surgical site infection, and blood transfusion both enhances inflammation and 
suppresses immunity [78]. 
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8.3 Antimicrobials prophylaxis 
In the present study, we identified that 61.3% (176/287) of the in-hospital patients were given AMP 
after orthopedic surgery, from which 62.5% (120/192) of the in-hospital patients were given AMP 
after orthopedic spinal surgery. To our knowledge, according to the American Society of 
Health-System Pharmacists Therapeutic Guidelines, AMP is recommended for orthopedic spinal 
procedures with and without instrumentation[36]. However, Chinese national guideline [37, 38] 
shows that AMP is not recommended in general, in which there is no detailed and specific 
recommendation that AMP should be used for orthopedic spinal procedures in China[38]. The only 
exception to the guideline[37] is that the cases with high risk factors (such as total hip arthroplasty, 
total knee arthroplasty, instrumentation and other factors among the orthopedic surgeries) are 
recommended to use AMP.    
 
In addition, we identified a first or second generation cephalosporin of AMP prescription was 
administered for routine of surgical prophylaxis. This finding was consistent with the 
recommendations [40, 79] referred by Ministry of Health in China and identified by studied 
article[80]. However, the mean duration of prophylactic antimicrobials administration was 2.2 days, 
which exceeded the recommendation to being within 24 hours postoperative period [40, 80].  
 
8.4 Traditional Chinese Medicine 
We described the use of TCM, but cannot conclude on its effect to prevent SSI, though the 
literatures [81, 82] have shown that TCM such as “Panax notoginseng saponins” prescribed in this 
study could induce the biological effects[46] to combat pathogens. To date, there is no scientific 
evidence that patient being treated with TCM is less likely to develop SSI. However, to our 
knowledge, this is the first study evaluating the association between the use of TCM and SSI 
following spinal surgery using a prospective cohort study, and thereafter more relevant researches in 
this area are needed. 
 
26 
 
8.5 Microorganism 
In the present study, we identified only few microorganisms in the postoperative procedures. To our 
knowledge, bacteria isolation is recommended before antibiotics administrated according to 
“Special Rectification Program for the Clinical Application of Antibiotics in 2013”[83] published 
by Ministry of Health in China. A possible explanation could be that preforming postoperative 
bacteria isolations to patients without medical insurance coverage is costly, and thereafter it seems 
likely that healthcare providers prioritized the orthopedic SSI prevention effort in the application of 
antimicrobials if the cases being threaten by orthopedic SSI. 
 
9 Limitations 
A limitation is that the present study was underpowered. A review article suggested that a sample 
size would be 456 or larger, which is the sample size required to estimate the incidence, given 
α=0.05, δ=0.02, and expected incidence=5.0% [45]. Also, the result cannot be generalized due to 
enrolling the cases from only one orthopedic ward. This incidence rate of SSI is therefore not a 
representative to the entire hospital.  
 
The interviewers were in shortage of techniques and skills to probe the patients to respond to the 
PDS-questionnaire. In addition, the information bias/recall bias might occur due to phone-interview 
only being performed up to 30 days post-discharge. The terminologies documented in questionnaire 
(Annex 10) to the phone-interview might be difficult to understand for some patients as a fact that 
can influence the authenticity of datasets. 
 
Some studies referred that the nutritional status, hypothermia [84] in intra-operative period, 
intra-operative supplemental oxygen [85] and preoperative infections (e.g. urinary tract infection) 
might be association with orthopedic SSI. However, the present study did not include these factors.  
 
This study also did not document the site-observational information regarding intra-operative 
characteristics such as surgical scrub, surgeon skill/techniques, and temperature and humidity of 
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operation theatre, which might influence of the quality of intraoperative procedures. 
 
10 Strengths 
This study made available information about the burden of SSI and its risk factors in a selected 
hospital in China using standardized surveillance method. This project also documented the use of 
TCM, from which was not currently documented in published study.  
 
Many studies are conducted retrospectively [34, 50, 86-88], while in this project we conducted a 
prospective cohort study focusing on the patients after orthopedic surgery to identify the risk factors 
associated with SSI.  
 
In this study, most of the answers to the questionnaires (Annex 9) filled by surgeons were 
completed. Only the variables (body mass index and white blood cell count after surgery) had some 
missing information.    
 
Finally, this study had used routine data of the surveillance system in the Dong Guan Hospital of 
Traditional Chinese Medicine and thus established methods for routine evaluations of the work on 
infection control in the hospital. 
 
11 Recommendations 
More studies with appropriated sample size are needed to identify risk factors associated with SSI 
among people undergoing spinal surgery.  
 
PDS in this hospital should be modified. Nurses should conduct post-discharge guidance that 
patients can report actively their medical situation of surgical incision if redness, swelling, pain and 
even purulent occurred. The interviewers in PDS should be trained about how to probe the patients 
to respond to the PDS-questionnaire. 
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To the risk factors identified in the present study, nursing care and attention is recommended to be 
paid particular to patients with wound classified as contaminated or dirty [67]; early drain removal 
is recommended [76]; careful monitoring of patients and taking close observations during and after 
administration of a blood transfusion is also recommended[78]. 
 
Dong Guan social and health insurance department should increase the health insurance coverage in 
the city. Medical expenditure in postoperative bacteria isolation is suggested to be covered by the 
health insurance.  
 
According to the international guideline, we suggest that AMP is administrated for orthopedic 
spinal procedures with and without instrumentation[36]. The duration of AMP administration 
should be less than 24 hours [40, 80]. Bacteria isolation is recommended before AMP 
administration [83].  
 
12 Conclusions  
This study has identified that an incidence proportion of SSI after orthopedic surgery was 2.8%, 
from which 3.6% developed SSI after spinal surgery in an orthopedic ward of Dong Guan Hospital 
of Traditional Chinese Medicine. Bivariate analysis indicated several significant risk factors, 
including wound contamination class, wound drains, blood transfusion. Intravenous AMP was given 
in 176 of 287 (61.3%) after orthopedic surgery. The average duration of AMP administration was 
2.2 days (range 1-9 days). Finally, the orthopedic SSI risk factors identified in present study may 
use to be for reducing the incidence of SSI in the future. 
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13 Appendices  
Annex 1 Criteria for Defining a Surgical Site Infection developed by CDC 
Superficial Incisional SSI [67] 
Infection occurs within 30 days after the operation 
And 
infection involves only skin or subcutaneous tissue of the incision 
and at least one of the following: 
1. Purulent drainage, with or without laboratory confirmation, from the superficial 
incision. 
2. Organisms isolated from an aseptically obtained culture of fluid or tissue from the 
superficial incision. 
3. At least one of the following signs or symptoms of infection: pain or tenderness, 
localized swelling, redness, or heat and superficial incision is deliberately opened by 
surgeon, unless incision is culture-negative. 
4. Diagnosis of superficial incisional SSI by the surgeon or attending physician. 
Do not report the following conditions as SSI: 
1. Stitch abscess (minimal inflammation and discharge confined to the points of 
suture penetration). 
2. Infection of an episiotomy or newborn circumcision site. 
3. Infected burn wound. 
4. Incisional SSI that extends into the fascial and muscle layers (see deep incisional 
SSI). 
Note: Specific criteria are used for identifying infected episiotomy and circumcision 
sites and burn wounds. 
 
Deep Incisional SSI 
Infection occurs within 30 days after the operation if no implant† is left in place or 
within 1 year if implant is in place and the infection appears to be related to the 
operation 
And 
infection involves deep soft tissues (e.g., fascial and muscle layers) of the incision 
and at least one of the following: 
1. Purulent drainage from the deep incision but not from the organ/space component 
of the surgical site. 
2. A deep incision spontaneously dehisces or is deliberately opened by a surgeon 
when the patient has at least one of the following signs or symptoms: fever (>38ºC), 
localized pain, or tenderness, unless site is culture-negative. 
3. An abscess or other evidence of infection involving the deep incision is found on 
direct examination, during reoperation, or by histopathologic or radiologic 
examination. 
4. Diagnosis of a deep incisional SSI by a surgeon or attending physician. 
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Notes:  
1. Report infection that involves both superficial and deep incision sites as deep 
incisional SSI. 
2. Report an organ/space SSI that drains through the incision as a deep incisional SSI. 
 
Organ/Space SSI 
Infection occurs within 30 days after the operation if no implant† is left in place or 
within 1 year if implant is in place and the infection appears to be related to the 
operation 
And 
infection involves any part of the anatomy (e.g., organs or spaces), other than the 
incision, which was opened or manipulated during an operation and at least one of the 
following: 
1. Purulent drainage from a drain that is placed through a stab wound‡ into the 
organ/space. 
2. Organisms isolated from an aseptically obtained culture of fluid or tissue in the 
organ/space. 
3. An abscess or other evidence of infection involving the organ/space that is found on 
direct examination, during reoperation, or by histopathologic or radiologic 
examination. 
4. Diagnosis of an organ/space SSI by a surgeon or attending physician. 
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Annex 2 Wound contamination class 
Wound contamination class as described by Altemeier et al. [4, 52, 67]. 
Wound contamination classification  
Wound 
Contamination 
class 
Description 
W1 
A clean wound is an uninfected operative wound in which no inflammation is 
encountered and the respiratory, alimentary, genital or uninfected urinary tracts 
are not entered. In addition, clean wounds are primarily closed and, if necessary, 
drained with closed drainage. Operative incisional wounds that follow 
non-penetrating trauma should be included in this category. 
W2 
Clean-contaminated wounds are operative wounds in which the respiratory, 
alimentary, genital or uninfected urinary tracts are entered under controlled 
condition and without unusual contamination. Specifically operations involving 
the biliary tract, appendix, vagina and oropharynx are included in this category 
provided no evidence of infection or major break in technique is encountered. 
W3 
Contaminated wounds include open, fresh, accidental wounds. In addition 
operations with major breaks in sterile technique or gross spillage from the 
gastrointestinal tract, and incisions in which acute, non-purulent inflammation is 
encountered are included in this category. 
W4 
Dirty or infected wounds include old traumatic wounds with retained devitalised 
tissue and those that involve existing clinical infection or perforated viscera. This 
definition suggests that the organisms causing postoperative infection were 
present in the operative field before the operation. 
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Annex 3 The American Society of Anesthesiology physical status classifications 
Physical status classification developed by the American Society of Anesthesiology (ASA) [52, 67, 
89]. 
ASA physical status classification 
ASA score Description 
A1 Normally healthy patient 
A2 Patient with mild systemic disease 
A3 Patient with severe systemic disease that is not incapacitating 
A4 Patient with an incapacitating systemic disease that is a constant threat to life 
A5 
Moribund patient who is not expected to survive for 24 hours with or without 
operation 
 
Annex 4 Wound bacterial cultures 
Common Pathogens by Orthopedic surgery [4, 20] 
Operation Likely Pathogens* 
Total joint replacement 
a. Gram-positive cocci: Staphylococcus aureus; 
Coagulase-negative Staphylococci 
Closed fractures/use of nails, bone plates, b. Gram-negative bacilli 
Other internal fixation devices c. Enterobacteriaceae 
Functional repair without implant/device d. Gram-negative bacilli: Acinetobacter baumannii; 
Pseudomonadaceae Trauma 
Spinal surgery 
e. Staphylococcus aureus, coagulase-negative 
staphylococci and Pseudomonas aeruginosa. 
*Likely pathogens from both endogenous and exogenous sources. 
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Annex 5 Antimicrobial prophylaxes  
Recommended Doses and Re-dosing Intervals for Commonly Used Antimicrobials for Surgical 
Prophylaxis from ASHP Guidelines [36] 
Recommended Dose Half-life in Adults 
With Normal Renal 
Function, hr 
Recommended Redosing 
Interval (From Initiation 
of Preoperative Dose), hr 
c 
Antimicrobial Adults
 a
 Pediatrics 
b
 
Ampicillin 2 g 50 mg/kg 1–1.9 2 
Aztreonam 2 g 30 mg/kg 1.3–2.4 4 
Cefazolin 
2 g, 3 g for pts 
weighing≥120 kg 
30 mg/kg 1.2–2.2 4 
Cefuroxime 1.5 g 50 mg/kg 1–2 4 
Cefotaxime 1 g 
d
 50 mg/kg 0.9–1.7 3 
Cefoxitin 2 g 40 mg/kg 0.7–1.1 2 
Cefotetan 2 g 40 mg/kg 2.8–4.6 6 
Ceftriaxone 2g 
e
 50-75 mg/kg 5.4-10.9 NA 
Ciprofloxacin 
f
 400mg 10mg/kg 3-7 NA 
Clindamycin 900mg 10mg/kg 2-4 6 
Ertapenem 1g 15mg/kg 3-5 NA 
Fluconazole 400mg 6 mg/kg 30 NA 
Gentamicin 
g
 
5 mg/kg based on 
dosing weight 
(single dose) 
2.5 mg/kg 
based on 
dosing weight 
2-3 NA 
Levofloxacin 
f
 500mg 10mg/kg 6-8 NA 
Piperacillin– 
tazobactam 
3.375 g 
Infants 2–9 mo:  
80 mg/kg  
of the piperacillin 
component 
0.7-1.2 2 
Vancomycin 15 mg/kg 15 mg/kg 4–8 NA 
a Adult doses are obtained from the studies cited in each section. When doses differed between studies, expert opinion 
used the most-often recommended dose. 
b The maximum pediatric dose should not exceed the usual adult dose. 
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c For antimicrobials with a short half-life (e.g., cefazolin, cefoxitin) used before long procedures, redosing in the 
operating room is recommended at an interval of approximately two times the half-life of the agent in patients with 
normal renal function. Recommended redosing intervals marked as ‘‘not applicable’’ (NA) are based on typical case 
length; for unusually long procedures, redosing may be needed. 
d Although FDA-approved package insert labeling indicates 1g,14 experts recommend 2g for obese patients. 
e When used as a single dose in combination with metronidazole for colorectal procedures. 
f While fluoroquinolones have been associated with an increased risk of tendinitis/tendon rupture in all ages, use of 
these agents for single-dose prophylaxis is generally safe. 
g In general, gentamicin for surgical antibiotic prophylaxis should be limited to a single dose given preoperatively. 
Dosing is based on the patient’s actual body weight. If the patient’s actual weight is more than 20% above ideal body 
weight (IBW), the dosing weight (DW) can be determined as follows: DW = IBW + 0.4(actual weight – IBW). 
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Annex 6 Definition of the variables included for surveillance of surgical site 
infection 
Patients characteristics Definition of the variables [52, 67] 
Age Age at date of operation in years 
Date of hospital 
admission (Day) 
Date patient was admitted to hospital in order to undergo the operation under 
surveillance (YYYY-MM-DD). 
Gender The gender of the patient who undergoes the operation: M = Male, F = Female. 
BMI[90] BMI＞25 kg/m2, BMI≤25 kg/m2 
ASA score Annex 3 
Diabetes mellitus [91] 
Yes= Either fasting plasma glucose ≥ 7.0 mmol /l (126 mg/dl) or with a glucose 
tolerance test, two hours after the oral dose a plasma glucose ≥ 11.1 mmol/l 
(200 mg/dl). Otherwise =No 
Rheumatoid 
arthritis[92] 
Yes= X-rays of joints and blood test results are abnormal. 
Bone oncology[93] 
Yes= Bone imaging (clinical and skeletal interventional radiology), bone 
biomarkers (clinical and translational applications), skeletal complications, and 
bone pain (mechanisms and management). Otherwise =No 
Pre-operative stay 
The number of days from hospital admission to the day of the operation the 
patient is enrolled into the study for. 
Orthopedic 
instrumentation 
An orthopedic instrumentation is a device surgically placed into the body designed 
to restore function by replacing or reinforcing a damaged structure. 
Operation ICD-9-CM 
code of orthopedic 
surgery 
Defines in accordance with the standardized ICD-9-CM code 
Urgent operation 
Planning time of the operation. ‘Yes’ means urgent operation that was not planned 
at least 24 hours in advance. ‘No’ means elective operation that was planned at 
least 24 hours in advance. Y =Yes (urgent), N = No (elective), UNK = Unknown. 
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Skin preparation [94] 
Yes=skin preparation using chlorhexidine-, povidone-, iodine-based preparations. 
Otherwise =No 
Date of operation (Day) Date operation under surveillance was carried out (YYYY-MM-DD). 
Wound contamination 
class 
The wound contamination class as described in Annex 2: W1= Clean, W2 = 
Clean-contaminated, W3 = Contaminated, W4 = Dirty or infected, UNK = 
Unknown. (Annex 2) 
Duration of operation in 
minutes 
Duration of operation (in minutes) from skin incision to skin closure. In case of 
re-intervention within 72h after the primary procedure, the duration of the 
re-intervention is added to the duration of the primary procedure. 
The number 
participants in the 
orthopedic surgery 
Mark how many participants attend in the orthopedic surgery. 
Intraoperative blood 
loss 
Mark how many milliliter loss of blood during a surgical procedure.  
Date of discharge 
(Days) 
Date the patient was discharged from hospital where they underwent the operation 
under surveillance or date of in-hospital death. This date is used to calculate the 
number of post-operative in-hospital patient days. 
Wound bacterial 
cultures 
Annex 4 
White blood cell count The reference ranges index of WBC is 4~11×10^9/L for adult. 
Intraoperative blood 
transfusion 
The introduction of whole blood or blood component directly into the blood 
stream during the surgical procedure. 
Drains 
Yes= that a drain to remove fluids or discharges from the body, such as from a 
wound, sore, or cavity was inserted. Otherwise =no 
Date of last follow-up 
post-discharge 
Date last information on the patient was obtained after discharge from hospital, for 
example from surgeon (out-patient department or private practice) or general 
practitioner. This date is used to calculate the total amount of follow-up days 
(in-hospital and post-discharge) (YYYY-MM-DD). 
Antimicrobial 
prophylaxis 
Perioperative systemic administration of antimicrobial agent(s) at or within two 
hours prior to primary skin incision with the aim of preventing sepsis in the 
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operative site. Y =Yes (patient received surgical antimicrobial prophylaxis), N= 
No (patient did not receive surgical antimicrobial prophylaxis), UNK = Unknown. 
(Annex 5) 
Traditional Chinese 
Medicine 
TCM was documented to have biological effects on limb swelling and tissue 
healing and to be anti-inflammatory, promoting circulation and supporting 
tissue/bone healing. Y =Yes (patient received TCM after orthopedic surgery), N= 
No (patient did not receive TCM after orthopedic surgery), UNK = Unknown. 
Surgical Site Infection Presence of a surgical site infection for this operation (Annex1). 
Date of infection 
Date when the first clinical evidence of SSI appeared or the date the specimen 
used to make or confirm the diagnosis was collected, whichever comes first 
(YYYY-MM-DD). 
Type of Infection 
Type of infection (Annex1). S = Superficial incisional, D = Deep incisional, O = 
Organ/space, UNK = Unknown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
38 
 
Annex 7 Definition of incidence rate of orthopaedic spinal SSI and its possible 
risk factors 
Name of surgical procedures Incidence rate of SSI Possible risk factors 
Vertebroplasty 1%-3.7% [95, 96] 
ASA score, BMI, older age, longer 
operative time, and length of stay [95, 
97, 98] 
Spinal decompression 2.4%-8.6% [99-103] 
ASA score, BMI, diabetes, blood 
loss, and longer operative time [99, 
104-107] 
Spinal fusions 0.74%-4.4% [108-111] 
ASA score greater than 2, obesity, 
diabetes, longer operative time, 
orthopedic implant and prolonged 
duration of drains [72, 73, 111-113] 
 
Annex 8 Specific functions of common traditional Chinese medicine constituents 
Common TCM constituents Specific functions 
Panax notoginseng saponins 
Promote blood circulation, anti-inflammatory and analgesic 
activity, immunological adjuvant activity and 
immune-stimulatory action, and hemostatic activity[62]. 
Salvia miltiorrhiza Increase blood flow and promote blood circulation[114]. 
Lumbricus rubellus Promote blood circulation[115]. 
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Annex 9 The questionnaire for patients with orthopedic surgery 
Please fill in data for each patient who had surgery 
Admission Number (AD): Age:  Gender: 
Date of hospital admission: 
Weight(KG): Height(CM):                                  BMI=
Hypertension: Yes or No or Unknown  Diabetes mellitus (DM): Yes or No or Unknown 
Rheumatoid arthritis (RA): Yes or No or Unknown Bone oncology: Yes or No or Unknown 
Main Diagnosis: Date of operation: 
Type of orthopedic surgery: ICD-9-CM code:  
ASA score： A1   A2    A3    A4    A5 Would contamination class: C1   C2   C3   C4 
Skin preparation: Yes or No or Unknown Urgent operation: Yes or No or Unknown      
Instruments: Yes or No or Unknown Duration of operation in minutes: 
Orthopedic surgeries operation room NO. :        
The number of participants in the orthopedic surgery:           
Intraoperative blood Loss(ml) Drainage: Yes or No or Unknown 
Duration of drainage (Days): Total amount of drainage (ml): 
Intraoperative blood transfusion: Yes or No or Unknown Pre-operative staying: 
Antibiotic prophylaxis: Yes or No or Unknown Traditional Chinese Medicine: Yes or No or Unknown 
Type of AMP Dose Time of first dose Regime Time of last dose 
     
     
Type of CM Dose Time of first dose Regime Time of last dose 
     
     
Surgical Site Infection: Yes or No Type of SSI:  
Date of infection:  WBC: Normal or Abnormal or Unknown 
Isolate result: Antibiotic Resistance data:  
Date of discharge from the hospital (Day): Doctor signature: 
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Annex 10 The questionnaires for the patients discharge after 30 days of surgery  
Has green/yellow pus discharged from your surgical wound?  Yes or No 
Has the area around your surgical wound been unusually red (more than ½ cm on each side)?  
Yes or No 
Has a doctor (physician) opened the wound because of infection?  Yes or No 
Have you received antibiotic treatment because of infection in the surgical wound?  Yes or No 
Have you had a fever (above 38.5 °C) because of infection in the surgical wound?  Yes or No 
OTHER 
Date of last follow-up post-discharge: 
Surgical Site Infection:  Yes or No 
Type of SSI:                                                                                
Date of infection: 
*For telephone interview 
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Annex 11 Ethical Clearances in Norway 
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Annex 12 Ethical Clearances in China 
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Annex 13 Ethical Clearances in China (Translation version) 
Approval Form of Ethical Clearances  
by the Committee of Dong Guan Hospital of Traditional Chinese Medicine (TCM) 
Project Name: 
Healthcare-associated infections (HAIs) after orthopedic surgery performed 
in Dong Guan hospital of Traditional Chinese Medicine (TCM) in China 
Project Type □ Drug  □ Instrument  √ Others 
Professional areas Nosocomial infection 
Principal 
Investigator 
Jiancong Wang 
Review materials Research Protocol Review type Conference review 
Conference Date June 15, 2014 
Conference 
Location 
Conference room 
List of the Ethical Committee Members and signatures of the present committee members 
Position Name Sex Title Profession Unit Signature： 
Chairman 
Zheng 
Zhiwen 
Male 
Associate 
Professor 
Traditional 
Chinese medicine 
Dongguan Hospital 
of TCM 
Zheng Zhiwen 
Vice 
Chairman 
Cai Limin Male Professor Orthopedics 
Dongguan Hospital 
of TCM 
Cai Limin 
Committee 
Members 
He 
Zhongjia 
Male Professor Orthopedics 
Dongguan Hospital 
of TCM 
He Zhongjia 
Committee 
Members 
Dong 
Mingguo 
Male Professor Gastroenterology 
Dongguan Hospital 
of TCM 
Dong 
Mingguo 
Committee 
Members 
Ning 
Weimin 
Female Professor Neurology 
Dongguan Hospital 
of TCM 
Ning Weimin 
Committee 
Member 
Zhou 
Yongmei 
Female Professor Nursing 
Dongguan Hospital 
of TCM 
Zhou Yongmei 
Committee 
Member 
Zhou 
Shunliang 
Male Professor 
Traditional 
Chinese medicine 
Dongguan People's 
Hospital 
Zhou 
Shunliang 
Committee 
Member 
Luo 
Jiandong 
Male 
Assistant 
archivist 
Forensic medicine 
Dongguan Hospital 
of TCM 
Luo Jiandong 
Number of Ethical Committee 
Members: 8 
Attendance: 8 Absence: 0 
Withdraw: 
0 
Voting 
result 
Supporting 
votes: 8 
Supporting votes 
after necessary 
amendments: 0 
Votes for review 
after necessary 
amendments: 0 
Disagree 
votes: 0 
Votes for 
termination or 
suspension of 
the test: 0 
Votes of 
withdraw: 
0 
Remark: 1 = I clinical trial ; 2 = II clinical trial ; 3 = III clinical trial 4 = IV clinical trial 
5=imported drug registration; 6=instrument monitoring test; 7=others 
 
Address: No.22 Song Shan Lake Avenue, Dongguan, China.  Zip Code: 523000    
Contact: Jiancong Wang     Tel: 0769-26385528 
46 
 
 
Review Comments of the Ethical Committee: 
1. By the review of the Medical Ethics Committee of Dongguan Hospital of Traditional Chinese 
Medicine, the project review materials of Research on “Healthcare-associated infections (HAIs) 
after orthopedic surgery performed in Dong Guan hospital of Traditional Chinese Medicine” are 
approved. After discussion, it meets the quorum and conforms to the Ethical Principle of Human 
Subject Medical Research (Declaration of Helsinki). 
2. Given that this research may be related to the hospital administrative data, the researchers need to 
consciously avoid the risk of the hospital administration and protect the privacy and confidentiality 
of the participants in the data collection and data disclosure. 
3. This research may benefit both the subjects and the target population, help the medical staff 
improve the prevention and control consciousness of hospital infection and timely find the related 
risk factors of surgical site infections so as to give early intervention and achieve better prevention 
and control of surgical site infections. 
 
Agree to conduct this research. 
                                               Signature of Chairman          
                                                Zhiwen Zheng(Seal) 
                                                  June 15, 2014 
Attention: 
1. In the case of serious adverse events, please report it to the Ethical Committee within 24 hours 
after informed. 
2. Any change to the research proposal and the related materials need to be promptly reported to the 
Ethical Committee. 
3. As for the inter-annual research, please report to the Ethical Committee. 
4. Please apply for the re-review, if the research project will be incomplete before the expiration 
day. 
5. To complete the clinical researches, please submit the concluding report to the Ethical Committee 
for review. 
 
Statement: 
The Ethical Committee will be established and operated in accordance with the Management 
Standard for Clinical Research Ethical Review of Traditional Chinese Medicine. The outcome of 
review and work process would not be influenced by any organization or individual outside the 
Ethical Committee. 
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